Loading…
Loading…
FormFactor, Onto and Viavi pair strong 52-week gains with sharp one-week pullbacks, fitting a momentum anomaly strategy for volatile markets.
FormFactor (FORM) reported earnings 30 days ago. What's next for the stock?
Sale executed under pre-established Rule 10b5-1 trading plan; Slesser retains stake worth ~$64 million after 3% stake reduction.
Algert Global LLC trimmed its holdings in FormFactor, Inc. (NASDAQ: FORM) by 18.9% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 53,560 shares of the semiconductor company's stock after selling 12,500 shares during the period. Algert Global LLC owned 0.07% of FormFactor worth $8,566,000 at
FormFactor sells the cryogenic test equipment that superconducting and silicon-spin quantum chips need before anyone can trust them. The company posted record second-quarter revenue of $258.2 million, a rarity in a sector full of cash-burning businesses.
The consensus price target hints at a 28.9% upside potential for FormFactor (FORM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Shares of semiconductor test equipment names are sliding Wednesday morning as a broad derisking wave hits some of 2026's biggest chip winners.
LIVERMORE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the following investor conferences: